Nanjing Darwingenetech

Nanjing Darwin Gene Technology is a biotechnology company specializing in precision medicine and molecular diagnostics. Based in Nanjing, China, the company utilizes advanced high-throughput sequencing (NGS) and liquid biopsy technologies to develop clinical solutions for oncology and reproductive health. Their core platform, Darwin-Seq, supports a range of applications including early cancer screening, companion diagnostics for targeted therapies, and non-invasive prenatal testing (NIPT). The company aims to integrate genomic data with clinical practice to provide personalized medical solutions and improve patient outcomes. Darwin Gene collaborates extensively with hospitals and research institutions to advance the application of genomic medicine in China.